MECHELEN, BELGIUM--(MARKET WIRE)--Jul 20, 2007 -- Mechelen, Belgium; 20 July 2007 - Galapagos NV (Euronext & LSE: GLPG) announced today that its BioFocus DPI service division has received a milestone payment in the autoimmune discovery research collaboration with Boehringer Ingelheim.
